STOUGHTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. Â (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious...
We look at five ETFs that can help investors leverage some of the trends expected to define the markets in the back half of the year.
STOUGHTON, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. Â (Nasdaq: COLL) a leading biopharmaceutical company focused on improving the lives of people living with serious and...
1 Healthcare Stock with Competitive Advantages and 2 We Question
1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm
1 Mooning Stock to Own for Decades and 2 That Underwhelm
2 Profitable Stocks to Keep an Eye On and 1 We Brush Off
3 of Wall Street’s Favorite Stocks We Approach with Caution
STOUGHTON, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. Â (Nasdaq: COLL) today announced it awarded inducement grants on June 1, 2026 under the Company's 2026 Inducement Plan...
2 Reasons to Sell COLL and 1 Stock to Buy Instead